Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SACHI BIOWORKS, INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2023-07-10 to 2026-10-19
Current total value of award: $1595236
Description: SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE